臺灣臨床試驗受試者招募實務及規範之進程

Clinical Trials Subject Recruitment, Regulations and Considerations in Taiwan

10.6320/FJM.202111_25(6).0016

吳倚晴(Yi-Ching Wu)；陳建煒(K. Arnold Chan)

受試者保護 ； 臨床試驗受試者招募 ； 受試者招募廣告 ； 潛在受試者 ； research subjects protection ； clinical trials subject recruitment ； advertisement for clinical trial subjects ； potential clinical trial subjects

台灣醫學

25卷6期（2021 / 11 / 25）

843 - 851

繁體中文

受試者保護在臨床試驗的每一個環節，都應被詳加考慮及落實；考量受試者之招募過程對受試者是否參與試驗有直接、重大之關鍵影響，本文由受試者招募實務之環節作為切入點，並彙整國內外近年臨床試驗受試者招募相關實務及規範之演變，以受試者保護為出發點提出分析及建議。

Protection of human research subject is crucial in clinical trials and should be carefully considered in every single step of a clinical trial. One important component in human subject protection is recruitment of potential clinical trial participants. In this article we reviewed the practical aspects of clinical trial subject recruitment from a human research protection perspective, considering the evolvement of relevant government guidance and regulations in Taiwan and latest global development as a result of advance in clinical trials methodology, changes in regulatory requirement in different countries, and utilization of information technology. We also made suggestions on practices of clinical trial teams and ethics review in Taiwan to support engagement in cutting edge clinical trials.

1. 陳肇文：我國法規變遷對人體研究及臨床試驗之影響。醫療品質雜誌 2012;6:28-31。
   連結：
2. Nwaru BI, Soyiri IN, Simpson CR, et al: Building a recruitment database for asthma trials: a conceptual framework for the creation of the UK Database of Asthma Research Volunteers. Trials 2016; 17:264.
   連結：
3. Denburg MR, Razzaghi H, Bailey LC, et al: Using Electronic Health Record Data to Rapidly Identify Children with Glomerular Disease for Clinical Research. JASN 2019; 30(12):2427-2435.
   連結：
4. HC Eborall, MCW Stewart, Cunningham-Burley S, et al: Accrual and drop out in a primary prevention randomised controlled trial: qualitative study. Trials 2011; 12:7.
   連結：
5. Miller HN, Charleston J, Wu B, et al: Use of electronic recruitment methods in a clinical trial of adults with gout. Clinical Trials 2021; 18(1):92-103.
   連結：
6. Lemmens T, Miller PB. Regulating the Market in Human Research Participants. PLoS Med 2006; 3: e330.
   連結：
7. 劉宏恩：新藥臨床試驗受試者招募廣告、新聞宣傳之法規限制。月旦醫事法報告 2020;48:107-13。
8. 劉宏恩：評我國食藥署關於COVID-19疫苗臨床試驗受試者徵求及緊急授權使用(EUA)之政策。生物醫學 2020;13:237-9。
9. 陳仲嶙：生醫研究模式與夥伴關係的推進與挑戰：從美國「我們全體」研究計畫談起。法律與生命科學2019;8:1-28。
10. 全國法規資料庫：藥事法第5條。2018年1月31日。https://law.moj.gov.tw/LawClass/LawAll. aspx?pcode=L0030001/ Accessed May 13, 2021.
11. The European Union Clinical Trials Register. https://www.clinicaltrialsregister.eu/ctr-search/search/ Accessed May 13, 2021.
12. Australian New Zealand Clinical Trials Registry. https://www.anzctr.org.au/Default.aspx/ Accessed May 13, 2021.
13. 臨床研究情報ポータルサイト。 https://rctportal.niph.go.jp/ Accessed May 13, 2021.
14. 台灣藥物臨床試驗資訊網。https://www1.cde.org.tw/ct_taiwan/ Accessed May 13, 2021.
15. Find NCI-Supported Clinical Trials. https://www.cancer.gov/about-cancer/treatment/ clinical-trials/search/ Accessed May 13, 2021.
16. Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE). https://grade.bsc.gwu.edu/ Accessed May 13, 2021.
17. PreventCOVIDU. https://preventcovidu.org/ Accessed May 13, 2021.
18. CISCRP. https://www.ciscrp.org/ Accessed May 13, 2021.
19. PatientsLikeMe. https://www.patientslikeme.com/ Accessed May 13, 2021.
20. MyHealthTeams. https://www.myhealthteams.com/ Accessed May 13, 2021.
21. Clinical Study Guide. https://www. guidetoclinicaltrials.com/ Accessed May 13, 2021.
22. Browse Clinical Trials by Health Volunteer Participation. https://www.australianclinicaltrials. gov.au/browse/healthy/ Accessed May 13, 2021.
23. 1 day sooner. https://www.1daysooner.org/ Accessed May 13, 2021.
24. 徐千惠、吳馥羽、吳彥慧：人體攻毒試驗應用於疫苗研發：過去、今日與未來。當代醫藥法規月刊 2020;120:1-16。
25. Drug Information Association. https://www. diaglobal.org/ Accessed May 13, 2021.
26. European Patients’ Academy on Therapeutic Innovation. https://eupati.eu/ Accessed May 13, 2021.
27. National Health Council. https://nationalhealth council.org/ Accessed May 13, 2021.
28. Clinical Trials Transformation Initiative. https://www.ctti-clinicaltrials.org/ Accessed May 13, 2021.
29. Murray MS: Co-Creating Global Capacity for Systematic Patient Engagement. https:// globalforum.diaglobal.org/issue/May-2021/co-creating-global-capacity-for-systematic-patient-engagement/ Accessed May 13, 2021.
30. 三軍總醫院：臨床試驗受試者招募原則。2007年6月6日。https://wwwv.tsgh.ndmctsgh. edu.tw/unit/10003/23281/ Accessed May 13, 2021.
31. 台北醫學大學人體研究處：修正案申請相關表單。2013年5月31日。http://ohr.tmu.edu.tw/ front/tmujirb/application/news.php?ID=dG11X29ociZhcHBsaWNhdGlvbg==&Sn=23/ Accessed May 13, 2021.
32. 衛生福利部食品藥物管理署：106年度藥品臨床試驗前瞻性法規環境研析-臨床試驗受試者招募管理原則研析(MOHW106-FDA-D-113-000451)研究成果報告。臺北，衛福部，2017。
33. 全國法規資料庫：藥品優良臨床試驗作業準則第83條。2020年8月28日。https://law.moj.gov.tw/LawClass/LawAll.aspx?PCode=L0030056/ Accessed May 13, 2021.
34. 台灣藥物法規資訊網：衛署藥字第0960317637號。2007年6月6日。http://regulation.cde.org.tw/doc_data_display?sid=1557&doctype2=/ Accessed May 13, 2021.
35. 台灣藥物法規資訊網：FDA藥字第1070014500號函。2018年7月9日。http://regulation.cde.org.tw/doc_data_display?sid=2676&doctype2=/ Accessed May 13, 2021.
36. 衛生福利部：因為有您，疫苗有譜，「COVID-19疫苗臨床試驗意向登記平台」正式上線。2020年11月11日。https://www.mohw.gov.tw/ cp-16-56637-1.html/ Accessed May 13, 2021.
37. 中央通訊社：疫苗試驗平台惹議，衛福部：收集意願非招募受試者。2020年11月16日。https://www.cna.com.tw/news/ahel/202011160059.aspx/ Accessed May 13, 2021.
38. 衛生福利部中央健康保險署：因為有您疫苗有譜。2020年11月11日。https://www.nhi.gov.tw/Nhi_E-LibraryPubWeb/Epaper/ItemDetail.aspx?DataID=5754&IsWebData=0&ItemTypeID=5&PapersID=558&PicID=/ Accessed May 13, 2021.